CureMetrix

02/14/2026

Protect the hearts you love. 💕
Happy Valentines day.

02/03/2026

Advancing women’s health—together.
CureMetrix is proud to partner with Rezolut Imaging to bring AI solution for breast arterial calcification (BAC) detection to routine mammography through cmAngio®. This collaboration reflects a shared commitment to expanding the clinical value of breast imaging and turns a routine mammogram into a 2-for-1 exam.
This collaboration aligns with Rezolut’s growing national presence within Envision Radiology and its focus on advancing imaging innovation.
https://www.einpresswire.com/article/889064888/curemetrix-brings-cmangio-bac-detection-to-rezolut-imaging-patients

02/02/2026

Today marks the kickoff of American Heart Month–a time to raise awareness about heart health and the unique risks women face at every stage of life. Heart disease remains the leading cause of death for women in the United States, and risk can begin earlier than many realize, even in your 20s, 30s, and 40s. You’re never too young to start paying attention to your heart health. Learn more from the NIH: https://www.nhlbi.nih.gov/health-topics/education-and-awareness/heart-truth/listen-to-your-heart
At CureMetrix, we are committed to advancing research that enhances the value of routine screening programs worldwide. Our ongoing efforts focus on improved understanding of breast arterial calcifications (BAC) and their potential association with cardiovascular disease (CVD) and chronic kidney disease (CKD), supporting a broader view of women’s health through imaging innovation. You can read more about our latest research here.
https://curemetrix.com/research-heart-health/

National Heart, Lung, and Blood Institute (NHLBI) American Heart Association

11/07/2025

🚀 We’re thrilled to announce that CureMetrix, Inc. has officially joined the Innovators’ Network at the Heart Association Center for Health Technology & Innovation! ❤️💡
This partnership will enable us to:
✅ Collaborate with experts and organizations driving cardiovascular innovation and advancing technology for women’s health.
✅ Leverage evidence-based scientific guidelines to build healthcare tech that truly makes a difference.
✅ Continue our mission of using responsible, science-driven AI to empower clinicians and improve patient outcomes.
Our CEO, Navid Alipour, shared:
“Being part of this network of innovators allows us to collaborate with organizations that share our vision for advancing healthcare through responsible, science-driven AI.”
We’re excited to expand our reach and impact—bringing forward AI innovations that help clinicians and patients every day. Stay tuned for what’s next! 👀📢

10/22/2025

We are at talking about women’s health.

Early breast cancer detection saves lives, and now with CureMetrix cmAngio as the only FDA cleared detecting breast arterial calcification, women get a “2 for 1” benefit from the same mammogram! Now available at hundreds of sites nationwide.

10/08/2025

The convergence of healthcare & hot topic in during DM us if you’d like to meet!

09/04/2025

Our President, Kevin Harris, joined The Healthy Enterprise podcast by The Bullzeye Media to talk about his journey in tech, co-founding CureMetrix, and using AI to improve

He discusses the role of in mammography, the integration of AI in radiology, and the regulatory and cultural challenges of advancing AI in healthcare. He also shares leadership lessons, thoughts on mentorship and education, and strategies for building a successful healthcare tech company.

🎧 Give it a listen: https://healthyenterprise.transistor.fm/episodes/clarity-through-technology-imaging-innovation-for-women-s-health-with-kevin-harris

08/05/2025

We’ll be at the 29th Annual Mammography in Santa Fe conference August 4–7! It’s one of the most comprehensive events of the year, with a focus on , tomosynthesis, and hands-on learning. If you’ll be there and want to meet up, send us a DM!

07/22/2025

We’re honored cmAngio® was included in this powerful session focused on the role of AI in advancing women’s health. Our FDA-cleared AI solution identifies breast arterial calcifications (BAC) on screening mammograms, enabling a mammogram to serve as a two-for-one exam by screening for breast cancer while also detecting BAC. Thank you Jyoti Gupta!

To learn more about cmAngio please visit: https://curemetrix.com/cmangio/

07/21/2025

This year, we’re proud to walk in the American Heart Association ❤️ 2025 San Diego Heart & Stroke Walk! We’re walking not only for our health but for yours and the well-being of our parents, children, and future generations.​

Join us in raising awareness for this important cause. Together, we can make a difference! 👊

The Heart Walk is the American Heart Association's premiere event for raising funds to save lives from USA's #1 and #5 killers - heart disease and stroke.

07/10/2025

💡 What if a routine mammogram could reveal more than breast cancer?

FDA-cleared cmAngio® is an AI-based software that reads mammograms and detects and localizes Breast Arterial Calcifications (BAC), providing additional clinical insight from a standard screening exam. It’s a two-for-one exam—screening for breast cancer while also detecting BAC—adding value without extra radiation or changes to existing workflows.

Already in use across the U.S., cmAngio is helping radiologists deliver more with the same image.

Interested in bringing cmAngio to your practice? Send us a message to learn more or visit: https://curemetrix.com/cmangio/

05/29/2025

At CureMetrix, we're a global leader in AI-driven medical imaging solutions, committed to advancing technology that supports radiologists and their patients.

Our product cmAngio enables a mammogram to serve as a two-for-one exam, screening for breast cancer while also detecting breast arterial calcifications (BAC). Radiologists can seamlessly integrate cmAngio into their workflow, enhancing their ability to identify these incidental findings. This AI-powered advancement maximizes the clinical value of a single mammogram, offering additional insights without added radiation or changes to standard procedures.

To learn more about cmAngio, please send us a message or visit: https://curemetrix.com/cmangio/